Dávila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, Guérin F, Hoskin P, Krasin MJ, Kroon P, Magelssen H, Mercke C, Merks JHM, Paulsen F, Pommier P, Ramos M, Rees H, Rogers T, Schmid M, Seitz G, Slater O, Smeulders N, Stenman J, Terwisscha S, Chargari Cet al.(2024) Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines Radiother Oncol, 110273(in press) DOI 10.1016/j.radonc.2024.110273, PubMed 38588921
Zhou Y, Ray PS, Zhu J, Stein F, Rettel M, Sekaran T, Sahadevan S, Perez-Perri JI, Roth EK, Myklebost O, Meza-Zepeda LA, von Deimling A, Fu C, Brosig AN, Boye K, Nathrath M, Blattmann C, Lehner B, Hentze MW, Kulozik AE(2024) Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma Nat Commun, 15(1), 2810 DOI 10.1038/s41467-024-47031-y, PubMed 38561347
Machak GN, Bruland ØS, Romanova TN, Kovalev AV(2024) Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal J Bone Oncol, 45, 100596 DOI 10.1016/j.jbo.2024.100596, PubMed 38545297